The Pharmacokinetics and Safety of IDV/r With NRTIs in HIV/TB Co-infected Patients Receiving Rifampicin
about
The Pharmacokinetics and Safety of IDV/r With NRTIs in HIV/TB Co-infected Patients Receiving Rifampicin
description
clinical trial
@en
klinisch onderzoek
@nl
name
The Pharmacokinetics and Safet ...... Patients Receiving Rifampicin
@en
The Pharmacokinetics and Safet ...... Patients Receiving Rifampicin
@nl
type
label
The Pharmacokinetics and Safet ...... Patients Receiving Rifampicin
@en
The Pharmacokinetics and Safet ...... Patients Receiving Rifampicin
@nl
prefLabel
The Pharmacokinetics and Safet ...... Patients Receiving Rifampicin
@en
The Pharmacokinetics and Safet ...... Patients Receiving Rifampicin
@nl
P1050
P1476
The Pharmacokinetics and Safet ...... ning Anti-tuberculosis Therapy
@en
P17
P3098
NCT00411996
P4844
P580
2006-12-01T00:00:00Z
P582
2008-10-01T00:00:00Z